BDBM582691 US11548860, Compound 12::Z2234185123

SMILES O=C1COc2cc(NC(=O)c3cc(NC(=O)c4cn[nH]c4)ccc3Cl)ccc2N1

InChI Key InChIKey=HHTNDRYAJNQCEV-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 582691   

TargetAromatase(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 60nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetCytochrome P450 3A4(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 1.83E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetCytochrome P450 2C9(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 2.25E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetCytochrome P450 2D6(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetSteroid 17-alpha-hydroxylase/17,20 lyase(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetCytochrome P450 2C19(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent

TargetCytochrome P450 1A2(Human)
Mangosuthu University of Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 582691BDBM582691(Z2234185123 | US11548860, Compound 12)
Affinity DataIC50: 5.00E+4nMAssay Description:The compounds were tested for inhibition of metabolic enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
US Patent